Navigation Links
Insmed Announces Planned Departure Of Chief Financial Officer
Date:7/30/2012

MONMOUTH JUNCTION, N.J., July 30, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the lung, today announced that the Company's Executive Vice President & Chief Financial Officer, Kevin Tully, will be leaving the Company when his current contract expires on December 1, 2012 due to family reasons.  Insmed has begun its search to identify candidates to replace Mr. Tully in the CFO role. 

"I would like to thank Kevin for his considerable contributions to Insmed in the 11 years he has spent with the Company," said Timothy Whitten, Insmed's President and Chief Executive Officer. "He was instrumental in enabling the successful combination of Insmed and Transave, as well completing a number of other critical initiatives during his tenure.  We wish him well in all his future endeavors."

About Insmed

Insmed Incorporated is a biopharmaceutical company focused on the development of innovative inhaled pharmaceuticals for the site-specific treatment of serious lung diseases.  Insmed's primary focus is on the development of inhaled antibiotic therapy delivered via proprietary advanced liposomal pulmonary technology in areas of high unmet need.  For more information, please visit http://www.insmed.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to Mr. Tully's departure and the search for his replacement constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, delays in our ability to find a replacement for Mr. Tully.  Investors are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release.  We undertake no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events.

Investor Relations Contact:
Brian Ritchie – FTI Consulting
212-850-5683
brian.ritchie@fticonsulting.com

Media Contact:
Irma Gomez-Dib – FTI Consulting
212-850-5761
irma.gomez-dib@fticonsulting.com


'/>"/>
SOURCE Insmed Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Insmed to Host 2012 Second Quarter Earnings Conference Call
2. Insmed To Present At JMP Securities 7th Annual Healthcare Conference
3. Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease
4. Insmed Announces First Quarter 2012 Financial Results
5. Insmed Incorporated Announces Lifting of Clinical Hold by U.S. Food and Drug Administration on ARIKACE® in Cystic Fibrosis Patients With Pseudomonas Lung Infections
6. Insmed to Host 2012 First Quarter Earnings Conference Call
7. Absorption Systems announces novel test platform for interactions with the BCRP transporter
8. Novogen Announces Merger Agreement With Kai Medical And Distribution Of Mei Pharma Shares
9. Aethlon Medical Announces the Appointment of Thomas V. Wornham and Philip A. Ward to its Board of Directors
10. IRIDEX Announces Second Quarter 2012 Conference Call and Release Date
11. Gentris Corporation Announces Collaboration to Study Blood Stability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2020)... ... February 20, 2020 , ... Enquire, a leading provider of cloud CRM, marketing ... to announce G5 as a Silver Sponsor of Enquire Summit 2020, scheduled for April ... to Enquire Summit as a Silver Sponsor. This event truly empowers sales and marketing ...
(Date:2/19/2020)... ... February 19, 2020 , ... Aspire Regenerative, a leader in offering therapies ... Pharmacy for a free weight-loss event on March 1, 2020. It will take place ... Jolla, CA, 92037. , During the event, physicians and pharmacists will lead an informative ...
(Date:2/19/2020)... ... February 19, 2020 , ... ... data management, has released a new SnapGene integration. This integration ... a ‘Quick View’ of supported DNA files, the molecular biology community has ...
Breaking Medicine Technology:
(Date:2/21/2020)... (PRWEB) , ... February 21, 2020 , ... ... that it is now offering a 10 percent grand opening discount 0n its ... percent off all purchases," said Osmay Gonzalez, spokesperson for Baby Blendy LLC, a ...
(Date:2/21/2020)... ... February 21, 2020 , ... ... and lifestyle solutions, has announced its third and final round of Canada finalists ... Period’s finalists are John Birr of Markdale, Ontario; Taiya Farrell of Winnipeg, Manitoba; ...
(Date:2/19/2020)... ... February 19, 2020 , ... Spaulding Youth Center ... from the Doug Flutie, Jr. Foundation for Autism. The grant will directly support ... The physical fitness program will include the hiring of a fitness professional who ...
(Date:2/19/2020)... , ... February 19, 2020 , ... ... which expanded the scope of regulations and requirements that currently govern medical device ... three years, which extends until 25 May 2020. Major changes from the previous ...
(Date:2/16/2020)... , ... February 16, 2020 , ... ... announced that it is partnering with AABB and The Joint Commission to provide ... management for PBM teams (directors, managers, coordinators and transfusion safety officers) within U.S. ...
Breaking Medicine News(10 mins):